City

Maastricht (1)

Paris (1)

Stuttgart (1)

Tuebingen (1)

Condition

Leukemia, Chronic Lymphatic (3)

Mantle Cell Lymphoma (1)

Overall Status

Completed (1)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

European Georges Pompidou Hospital (1)

Maastricht Radiation Oncology (1)

University Hospital Tuebingen (1)

Collaborator

Katharinenhospital Stuttgart (1)

Klinikum Stuttgart (1)

Marienhospital Stuttgart (1)

Robert Bosch Gesellschaft fur Medizinische Forschung mbH (1)

Intervention

imiquimod (1)

peptide vaccine (1)

splenic irradiation (1)

Study Documents

Intervention Type

biological (1)

drug (1)

radiation (1)

Funder Type

Other (3)

Study Type

Observational (2)

Interventional (1)

leukemia, chronic lymphatic

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

Completed

Leukemia, Chronic Lymphatic

Peptide Vaccine
Imiquimod

Stuttgart, Baden-Wuerttemberg, Germany
+4 more

Nov 24, 2022

Atrial Fibrillation in Patients Receiving Ibrutinib

Recruiting

Leukemia, Chronic Lymphatic
Mantle Cell Lymphoma

Paris, France

Assistance Publique Hôpitaux de Paris - Centre Université de Par

Jun 4, 2020

Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia

Withdrawn

Leukemia, Chronic Lymphatic

splenic irradiation

Maastricht, Netherlands

Maastro Clinic

Apr 4, 2018